NFL BIOSCIENCES (EPA:ALNFL)

BRIEF

published on 03/05/2025 at 17:50, 10 days 22 hours ago

NFL Biosciences Releases 2025 Financial Agenda

NFL Biosciences Addiction Treatment Biopharmaceutical Botanical Drugs Financial Agenda 2025
REGULATED PRESS RELEASE

published on 03/05/2025 at 17:45, 10 days 22 hours ago

NFL Biosciences publishes its 2025 financial agenda
NFL Biosciences announces its 2025 financial agenda, including key events such as annual results and AGM. The biopharmaceutical company focuses on developing botanical drugs for addictions

NFL Biosciences Biopharmaceutical Botanical Drugs 2025 Financial Agenda Addictions
BRIEF

published on 02/04/2025 at 07:05, 1 month 12 days ago

NFL Biosciences Highlights Safety of NFL-101 in New Study

Clinical Trials Treatment Development NFL-101 Safety Tobacco Addiction Regulatory Process
REGULATED PRESS RELEASE

published on 02/04/2025 at 07:00, 1 month 12 days ago

NFL Biosciences publishes positive results from a complementary program confirming the excellent safety profile of NFL-101, its first-in-class treatment for tobacco addiction
NFL Biosciences reports positive results from toxicity study on NFL-101, showing superior safety profile for tobacco addiction treatment, enhancing potential for Phase 3 development

NFL Biosciences NFL-101 Phase 3 Development Safety Profile Tobacco Addiction
REGULATED PRESS RELEASE

published on 12/05/2024 at 08:02, 3 months 11 days ago

NFL BIOSCIENCES VALIDATES THE INDUSTRIALIZATION OF NFL-101 FOR SMOKING CESSATION
BRIEF

published on 11/18/2024 at 17:50, 3 months 27 days ago

NFL Biosciences Presents NFL-101 at Tobacco Congress

NFL Biosciences Smoking Cessation NFL-101 Tobaccology Disruptive Mechanism
REGULATED PRESS RELEASE

published on 10/18/2024 at 08:00, 4 months 29 days ago

NFL BIOSCIENCES: LEADERSHIP TEAM PREPARING THE NEXT STAGES IN ITS DEVELOPMENT
REGULATED PRESS RELEASE

published on 10/08/2024 at 08:00, 5 months 8 days ago

NFL BIOSCIENCES: EFFICACY VALIDATED THROUGH UPDATED ANALYSES FROM CESTO II FOR SMOKING CESSATION. SIGNIFICANT REDUCTION IN CRAVING. STRONG COMMERCIAL POTENTIAL CONFIRMED.
BRIEF

published on 09/27/2024 at 17:50, 5 months 18 days ago

NFL BIOSCIENCES: 2024 First-Half Business and Earnings Update

Capital Increase NFL-101 Phase 3 Trial NFL-301 Clinical Developments
REGULATED PRESS RELEASE

published on 09/27/2024 at 17:45, 5 months 18 days ago

NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
NFL Biosciences reports 2024 first-half business and earnings update, showcasing advancements in smoking cessation drug candidate NFL-101 and alcohol consumption drug candidate NFL-301

NFL Biosciences Smoking Cessation Botanical Drugs 2024 First-half Earnings Alcohol Consumption

1 2 ... 4

Published on 03/16/2025 at 13:45, 2 hours 23 minutes ago

SEG Announced 2024 Annual Results Total Value of New Contracts Exceeded RMB 100 Billion With Record Dividend Payouts
Published on 03/15/2025 at 00:40, 1 day 15 hours ago

Star Copper Announces Execution of Arrangement Agreement For Spin-Out of Okeover Project
Published on 03/15/2025 at 00:00, 1 day 16 hours ago

BioNxt Solutions Announces Closing of Final Tranche of Fully Subscribed Convertible Debenture Unit Private Placement
Published on 03/14/2025 at 23:20, 1 day 16 hours ago

Organto Foods Provides Update on Strategic Plans
Published on 03/14/2025 at 22:55, 1 day 17 hours ago

Alset AI Announces Filing of Audited Financial Statements

View all ACCESSWIRE

Published on 03/16/2025 at 14:15, 1 hour 53 minutes ago

X-PITCH 2023 Announces Global TOP100 Startups
Published on 03/14/2025 at 20:20, 1 day 19 hours ago

EQS-Adhoc: Gläubigerversammlung zur Anleihenverlängerung
Published on 03/14/2025 at 18:44, 1 day 21 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/14/2025 at 18:02, 1 day 22 hours ago

Form 8.1(c) - Dalata Hotel Group PLC:
Published on 03/14/2025 at 17:55, 1 day 22 hours ago

Funding Circle Plc: POS-Transaction in Own Shares

View all EQS

Published on 03/14/2025 at 18:55, 1 day 21 hours ago

Availability of ENGIE's 2024 Universal Registration Document
Published on 03/14/2025 at 18:00, 1 day 22 hours ago

Availability of the 2024 Universal Registration Document of OPmobility SE
Published on 03/14/2025 at 16:55, 1 day 23 hours ago

Closing of the agreement between ENGIE and the Belgian government
Published on 03/14/2025 at 11:34, 2 days 4 hours ago

Statement about the number of shares composing the share capital and the number of voting rights as at February 28, 2025
Published on 03/14/2025 at 08:44, 2 days 7 hours ago

Aéroports de Paris SA - €1bn dual-tranche new bond issue

View all LES ECHOS COMFI WIRE

News